Brinton Pharma appoints Sathya Narayanan as CEO – India Cluster & JPAC
Industry veteran to lead Brinton’s expansion across India and key Asia Pacific markets
Industry veteran to lead Brinton’s expansion across India and key Asia Pacific markets
Elanco expects Befrena to launch in the US in the first half of 2026
PRX-PLUS has a unique product feature with its deep-impacting formula
The newly setup entity, Emcutix Biopharmaceuticals Limited, plans to significantly expand Emcure’s offerings
Agreed Price of US$43 per share to deliver 48% premium to unaffected price on May 25, 2023
The amalgamation will integrate business operations and provide impetus to the existing portfolio of Alembic
The company expects to see steady performance led by new launches and gradual normalization post the scale-up in vaccination
Subscribe To Our Newsletter & Stay Updated